Bank of Montreal’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $878K | Sell |
8,451
-3,408
| -29% | -$363K | ﹤0.01% | 2108 |
|
|
2025
Q4 | $1.22M | Buy |
11,859
+2,173
| +22% | +$211K | ﹤0.01% | 1875 |
|
|
2025
Q3 | $875K | Sell |
9,686
-1,712
| -15% | -$150K | ﹤0.01% | 2009 |
|
|
2025
Q2 | $1M | Sell |
11,398
-4,190
| -27% | -$363K | ﹤0.01% | 1903 |
|
|
2025
Q1 | $1.42M | Sell |
15,588
-6,989
| -31% | -$629K | ﹤0.01% | 1659 |
|
|
2024
Q4 | $1.95M | Buy |
22,577
+937
| +4% | +$84.8K | ﹤0.01% | 1562 |
|
|
2024
Q3 | $2.05M | Buy |
21,640
+6,570
| +44% | +$624K | ﹤0.01% | 1686 |
|
|
2024
Q2 | $1.41M | Buy |
15,070
+11,500
| +322% | +$1.03M | ﹤0.01% | 1844 |
|
|
2024
Q1 | $325K | Buy |
3,570
+305
| +9% | +$26.7K | ﹤0.01% | 2728 |
|
|
2023
Q4 | $266K | Buy |
3,265
+125
| +4% | +$9.8K | ﹤0.01% | 2948 |
|
|
2023
Q3 | $260K | Sell |
3,140
-11,130
| -78% | -$897K | ﹤0.01% | 2910 |
|
|
2023
Q2 | $1.13M | Buy |
14,270
+8,570
| +150% | +$671K | ﹤0.01% | 2123 |
|
|
2023
Q1 | $442K | Sell |
5,700
-1,802
| -24% | -$139K | ﹤0.01% | 2530 |
|
|
2022
Q4 | $585K | Sell |
7,502
-1,942
| -21% | -$143K | ﹤0.01% | 2523 |
|
|
2022
Q3 | $666 | Buy |
9,444
+7,541
| +396% | +$555K | ﹤0.01% | 2409 |
|
|
2022
Q2 | $150 | Sell |
1,903
-100
| -5% | -$7.81K | ﹤0.01% | 3363 |
|
|
2022
Q1 | $161K | Sell |
2,003
-115
| -5% | -$8.8K | ﹤0.01% | 3534 |
|
|
2021
Q4 | $165K | Buy |
2,118
+99
| +5% | +$7.36K | ﹤0.01% | 3006 |
|
|
2021
Q3 | $148K | Hold |
2,019
| – | – | ﹤0.01% | 3381 |
|
|
2021
Q2 | $148K | Buy |
2,019
+219
| +12% | +$15.6K | ﹤0.01% | 3270 |
|
|
2021
Q1 | $122K | Hold |
1,800
| – | – | ﹤0.01% | 3313 |
|
|
2020
Q4 | $124K | Sell |
1,800
-400
| -18% | -$25.6K | ﹤0.01% | 3476 |
|
|
2020
Q3 | $135K | Hold |
2,200
| – | – | ﹤0.01% | 2927 |
|
|
2020
Q2 | $135K | Sell |
2,200
-300
| -12% | -$18.1K | ﹤0.01% | 2934 |
|
|
2020
Q1 | $132K | Sell |
2,500
-700
| -22% | -$43.1K | ﹤0.01% | 2491 |
|
|
2019
Q4 | $205K | Sell |
3,200
-150
| -4% | -$9.04K | ﹤0.01% | 3150 |
|
|
2019
Q3 | $191K | Buy |
3,350
+140
| +4% | +$8.02K | ﹤0.01% | 2935 |
|
|
2019
Q2 | $188K | Buy |
3,210
+100
| +3% | +$5.79K | ﹤0.01% | 2956 |
|
|
2019
Q1 | $189K | Buy |
3,110
+400
| +15% | +$23.6K | ﹤0.01% | 2750 |
|
|
2018
Q4 | $148K | Hold |
2,710
| – | – | ﹤0.01% | 2738 |
|
|
2018
Q3 | $174K | Hold |
2,710
| – | – | ﹤0.01% | 2825 |
|
|
2018
Q2 | $160K | Sell |
2,710
-194
| -7% | -$11.2K | ﹤0.01% | 2875 |
|
|
2018
Q1 | $165K | Hold |
2,904
| – | – | ﹤0.01% | 2720 |
|
|
2017
Q4 | $172K | Sell |
2,904
-90
| -3% | -$5.16K | ﹤0.01% | 2745 |
|
|
2017
Q3 | $173K | Buy |
2,994
+144
| +5% | +$8.18K | ﹤0.01% | 2726 |
|
|
2017
Q2 | $168K | Sell |
2,850
-100
| -3% | -$5.66K | ﹤0.01% | 2741 |
|
|
2017
Q1 | $163K | Hold |
2,950
| – | – | ﹤0.01% | 2585 |
|
|
2016
Q4 | $153K | Hold |
2,950
| – | – | ﹤0.01% | 2625 |
|
|
2016
Q3 | $170K | Hold |
2,950
| – | – | ﹤0.01% | 2516 |
|
|
2016
Q2 | $173K | Sell |
2,950
-100
| -3% | -$5.83K | ﹤0.01% | 2542 |
|
|
2016
Q1 | $175K | Sell |
3,050
-300
| -9% | -$17.7K | ﹤0.01% | 2538 |
|
|
2015
Q4 | $219K | Sell |
3,350
-1,300
| -28% | -$84K | ﹤0.01% | 2377 |
|
|
2015
Q3 | $293K | Sell |
4,650
-100
| -2% | -$7.03K | ﹤0.01% | 2085 |
|
|
2015
Q2 | $336K | Sell |
4,750
-200
| -4% | -$14.4K | ﹤0.01% | 2170 |
|
|
2015
Q1 | $348K | Sell |
4,950
-200
| -4% | -$13.6K | ﹤0.01% | 2119 |
|
|
2014
Q4 | $331K | Sell |
5,150
-400
| -7% | -$25.5K | ﹤0.01% | 2250 |
|
|
2014
Q3 | $353K | Buy |
5,550
+400
| +8% | +$24.8K | ﹤0.01% | 2260 |
|
|
2014
Q2 | $320K | Sell |
5,150
-300
| -6% | -$17.8K | ﹤0.01% | 2307 |
|
|
2014
Q1 | $318K | Sell |
5,450
-3,555
| -39% | -$201K | ﹤0.01% | 2296 |
|
|
2013
Q4 | $479K | Buy |
9,005
+700
| +8% | +$35.4K | ﹤0.01% | 1836 |
|
|
2013
Q3 | $397K | Sell |
8,305
-200
| -2% | -$9.48K | ﹤0.01% | 1916 |
|
|
2013
Q2 | $387K | Buy |
+8,505
| New | +$393K | ﹤0.01% | 1871 |
|
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Bank of Montreal's PPH Position: Q1 2026 in Review
Bank of Montreal reduced its VanEck Pharmaceutical ETF (PPH) stake by 29% in Q1 2026, selling an estimated $363K and leaving 8,451 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.
Bank of Montreal first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.05M in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Bank of Montreal held 8,451 shares of VanEck Pharmaceutical ETF worth $878K as of Q1 2026.
- Bank of Montreal sold 3,408 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $363K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2108 holding.
- Bank of Montreal first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's VanEck Pharmaceutical ETF position peaked at $2.05M in Q3 2024.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.